13F

Stock

Biomarin Pharmaceutical Inc

BMRN · held by 9 managers

Reported value

$539.5M

Holders

9

+2 new · −0 exited

Holders’ est. mark

−$72.7M

Price effect on 6 books still in the name

Largest holder

$511.4M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC6.78M$511.4M−$72.9MAdded$18.3M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main14.1M$26.9M$105KCut−$885.7K
Swiss Life Asset Management Ltd4.74K$458.7K$39KAdded$21.4K
Marex Group plc4.07K$392.3K$32.3KCut−$317.4K
Burton Enright Welch3.73K$359.2K$29.3KAdded$33K
Leonteq Securities AG311$30K$2.47KCut−$109.9K

Positions as of Q4 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.